House Rx's latest funding signals a shift in the specialty pharmacy landscape, challenging the dominance of PBM-owned networks with a more transparent, tech-enabled alternative. By embedding pharmacy services directly into specialty clinics, House Rx is addressing cost, access, and coordination issues that have long plagued patients with complex conditions. With the backing of top healthcare investors and a robust AI-driven platform, the company is poised to lead a transformation toward more equitable and patient-centered medication delivery in the U.S.